Picture EBD Group BioPharm America 2021 Digital BPA2021 650x80
Organisation › Details

ProZyme Inc.

ProZyme Inc. is a privately-owned company dedicated to advancing glycobiology research and improving biopharmaceutical analysis for optimal design and quality manufacturing of life saving therapies. The company supplies value-added kits, enzymes, standards and a complete CE system for biotherapeutic protein characterization and glycobiology research. ProZyme’s focus on R&D and innovation supports an agile product development program and a strong IP portfolio. *


Period Start 1990-01-01 established
Products Industry reagents (bio/biochemical)
  Industry 2 LC/MS (liquid chromatography/mass spectrometry)
Person Person Vlasenko, Sergey (ProZyme 201806 CEO)
Region Region Hayward, CA
  Country United States (USA)
  Street 3832 Bay Center Place
  City 94545 Hayward, CA
  Tel +1-510-638-6900
    Address record changed: 2020-12-02
Basic data Employees B: 11 to 50 (2018-06-28)
    * Document for �About Section�: Agilent Technologies Inc.. (6/28/18). "Press Release: Agilent Technologies to Expand Biopharma Consumables Portfolio with Acquisition of ProZyme". Santa Clara, CA.
Record changed: 2019-09-19


Picture Berlin Partner Berlin-Brandenburg Healthcare Industries Cluster 650x80px

More documents for Agilent (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Demy-Colton BioFuture 2021 NYC D Meet Top Investors 650x300px

» top